Scientific abstract of ILP100-Oral in two colitis models selected for poster at Experimental Biology Philadelphia April 4 2022

Experimental Biology (EB) is the annual meeting of five societies that explores the latest research in anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. Participants represent scientists from academic institutions, government agencies, nonprofit organizations and industry.

Ilya Pharma participating in Texas Life Science Forum, Houston 23-24 February 2022

Ilya Pharma presenting at Hybrid event BIO CEO Investor conference in NYC 14-17 February 2022

Open position as CMC project manager

Ilya Pharma invited to attend the 40th JP Morgan Health Care Conference 10-13 January, 2022

Largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

Ilya Pharma will present clinical and corporate updates at Biotech Showcase 10-13 January at JPM Week 2022

Ilya Pharma shares latest developments of ILP100-Oral at virtual conference 7th of December showcasing innovations in gut therapeutics

Professor Mia Phillipson will present Nature Conferences Innovative Tissue Therapies from Bench to Bedside 16-18 November

Abstract: "The ILP-technology platform is scalable and enables efficient delivery of immunoregulatory proteins locally on-site – lead program in clinical phase 2 developments"

Ilya Pharma will be participating at Jefferies London Healthcare Conference 16-19 November

Ilya Pharma will be participating at the Swedish American Life Science Summit 2021 October 20-22 and is nominated to the Rising Star Award